Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra
Donald L
DL
MUSC, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
D000818:Animals; D001943:Breast Neoplasms / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000517:prevention & control; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D016889:Endometrial Neoplasms / Q000453:epidemiology; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008252:Macaca fascicularis; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010349:Patient Compliance; D017698:Postmenopause; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D011817:Rabbits; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000139:chemically induced
D004967:Estrogens; D011372:Progestins